Latest News
Feature
Antiamyloid solanezumab fails to slow decline in mild Alzheimer’s
Solanezumab, a monoclonal antibody that targets amyloid plaques, did not slow cognitive decline in patients with mild Alzheimer’s disease.
Conference Coverage
PPIs may boost ischemic stroke risk
NEW ORLEANS – Use of proton pump inhibitors appears to be an independent risk factor for first ischemic stroke.
From the Journals
Mastoid stimulation significantly reduces episodic migraine frequency
Episodic migraines were safely and effectively treated using percutaneous mastoid electrical stimulators in a randomized, double-blind, sham-...
Feature
What will the Trump administration mean for medicine?
ACA repeal seems fairly likely; who will head the federal health care agencies is unknown.
Feature
Meaningful use: CMS extends 90-day reporting period to 2016, 2017
Several meaningful use requirements for doctors and hospitals were eased under the federal regulation that sets payments for the hospital...
Feature
Number of Medicare part D drug plans continues to decline
There will be 16% fewer Medicare part D prescription drug plans available in 2017, compared with 2016,
Feature
7 tips for successful value-based care contracts
Drafting clear, thoughtful contracts with payers is critical as physicians enter into new value-based care arrangements.
Article
MS relapse predictors identified after patients stop treatment
Patients with multiple sclerosis treated with interferon-beta or glatiramer acetate who are aged 45 and over and have no evidence of clinical...
From the Journals
Amyloid PET scans may have clinical utility in patients with cognitive impairment
Amyloid PET scans can affect diagnostic thinking and patient management when used alongside routine diagnostic work-up in adults suspected of...
From the Journals
Two migraine prevention drugs prove no better than placebo in children
Amitriptyline and topiramate, commonly used to prevent migraine in adults, were associated with significantly more adverse events than was placebo...
Feature
Drug prices, not the health law, top voters’ health priorities for 2017
Majorities of Democratic, Republican, and independent voters support making sure high-cost drugs for chronic conditions are affordable for...